Skip to content

Public FDA record

Z-2352-2024: Medtronic Ascenda Intrathecal Catheter, Models: a) 8780 (114 cm); b) 8781 (140 cm); c) 8784 (catheter

Recall record Z-2352-2024 for Medtronic Neuromodulation. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2352-2024
Company in FDA record
Medtronic Neuromodulation
FDA classification date
Jul 12, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Design update to the Ascenda Intrathecal Catheter Models 8780, 8781, and 8784. The intent of the design update is to reduce the potential for tissue growth into the Ascenda catheter connector which may potentially lead to catheter occlusion.

Source facts

Action
Medtronic issued an URGENT: MEDICAL DEVICE CORRECTION notice to its consignees on 05/10/2024 electronically (DocuSign) to each listed physician. For Physicians that do not have an email address or a DocuSign account, the Consignee Notification and Customer Confirmation Form were sent via mail UPS/USPS. The notice explained the issue, provided clinician and patient recommendations, and requested that the notice be shared with all those to whom the devices was transferred. If you have any questions regarding this communication, please contact Medtronic Technical Services at 1-800-707-0933 or your local Medtronic representative. On 03/12/2025, Medtronic issued an URGENT: MEDICAL DEVICE RECALL notice to its consignees via mail. The Consignee Notifications informs the customer of availability of Ascenda catheters with the new design and requests the return of Ascenda catheters that were manufactured prior to the design update of 05/10/2024, and requested that the notice be shared with all those to whom the devices was transferred. For questions, please contact Medtronic Technical Services at 1-800-707-0933 or your local Medtronic representative.
Initiated
2024-05-10
Root cause
Device Design
Distribution
Worldwide Distribution: US (nationwide) and OUS (foreign) countries of: Argentina, Aruba, Australia, Austria, Belgium, Brazil, Canada, Canary Islands, Chile, Colombia, Cyprus, Czech Rep, Denmark, Dominican Republic, Ecuador, Egypt, El Salvador, Estonia, Finland, France, Guadeloupe, Germany, Greece, Hong Kong, Hungary, Indonesia, Italy, Iran, Islamic Republic, Iraq, Ireland, Jordan, Kazakhstan, Korean Republic of, Kuwait, Latvia, Lebanon, Lithuania, Libya, Luxembourg, Malaysia, Malta, Mexico, Morocco, Netherland, New Zealand, Norway, Oman, Panama, Pakistan, Poland, Portugal, Qatar, Reunion, Romania, Russian Federation, Saudi Arabia, Serbia, Singapore, Slovenia, South Africa, Spain, Switzerland, Sweden, Taiwan, Thailand, Tunisia, Turkey, United Arab Emirate, and United Kingdom.
Recall number
Z-2352-2024
Recall status
Open, Classified
CDRH record ID
208260
FDA classified
2024-07-12
Recall event number
94779

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗